As AbbVie's Risankizumab Looms, Sun Pushes To 'Maximize Time' Of Ilumya

 
• By Anju Ghangurde
  
Management
SUN IS KEEN TO PUSH AHEAD WITH PLANS FOR ILUMYA AS MORE COMPETITION LOOMS
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip